Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

388
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
388
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

336
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
336
Production of Antibiotics01:27

Production of Antibiotics

285
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
285
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

225
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
225
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Antifungal Agents01:15

Antifungal Agents

132
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
132

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Familial collapsing focal segmental glomerulosclerosis.

Clinical nephrology·2011
Same author

Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression.

Clinical nephrology·2010
Same author

The treatment of acute interstitial nephritis: More data at last.

Kidney international·2008
Same author

Update on the treatment of lupus nephritis.

Kidney international·2006
Same author

The IgA nephropathy treatment dilemma.

Kidney international·2006
Same author

Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.

Kidney international·2006
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

18.9K

Gentamicin in 1978.

G B Appel, H C Neu

    Annals of Internal Medicine
    |October 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Gentamicin remains a vital antimicrobial agent due to its efficacy. Understanding its pharmacokinetics and toxicity patterns ensures efficient treatment, despite newer alternatives.

    More Related Videos

    A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus
    06:55

    A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus

    Published on: February 27, 2018

    8.2K
    Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
    08:38

    Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

    Published on: February 22, 2019

    5.3K

    Related Experiment Videos

    Last Updated: May 6, 2026

    The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
    12:21

    The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

    Published on: November 26, 2015

    18.9K
    A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus
    06:55

    A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus

    Published on: February 27, 2018

    8.2K
    Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
    08:38

    Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

    Published on: February 22, 2019

    5.3K

    Area of Science:

    • Pharmacology
    • Microbiology
    • Toxicology

    Background:

    • Gentamicin has been a widely used antimicrobial for ten years.
    • Concerns exist regarding increasing resistance, nephrotoxicity, ototoxicity, and newer aminoglycoside antibiotics.
    • This reassesses gentamicin's role in clinical practice.

    Purpose of the Study:

    • To re-evaluate the clinical utility of gentamicin.
    • To highlight the importance of pharmacokinetics and toxicity in gentamicin use.
    • To determine gentamicin's future role amidst newer antibiotics.

    Main Methods:

    • Review of existing literature on gentamicin.
    • Analysis of pharmacokinetic data.
    • Assessment of toxicity patterns in humans and animals.

    Main Results:

    • Gentamicin demonstrates significant antimicrobial efficacy.
    • Understanding pharmacokinetics and toxicity is crucial for effective use.
    • Despite newer agents, gentamicin's widespread use is likely to continue.

    Conclusions:

    • Optimizing gentamicin therapy requires knowledge of its pharmacokinetics and toxicity.
    • Gentamicin remains a valuable antimicrobial agent.
    • Its continued widespread use is anticipated in the near future.